Detalhe da pesquisa
1.
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
Br J Haematol
; 201(2): 256-266, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36740991
2.
High total metabolic tumor volume at baseline predicts survival independent of response to therapy.
Blood
; 135(16): 1396-1405, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978225
3.
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.
Eur J Haematol
; 2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29719933
4.
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Am J Hematol
; 91(4): 366-70, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689746
5.
Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.
Blood
; 119(22): 5104-10, 2012 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22337714
6.
Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study.
Am J Hematol
; 89(2): 174-80, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24123244
7.
Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation.
Blood
; 117(5): 1516-21, 2011 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21106985
8.
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
Blood
; 117(6): 2009-11, 2011 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20962323
9.
Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC.
Blood
; 117(23): 6109-19, 2011 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-21406717
10.
The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.
Haematologica
; 98(11): 1711-7, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23831922
11.
Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia.
Haematologica
; 103(7): e304-e306, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545348
12.
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Lancet
; 378(9806): 1858-67, 2011 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22118442
13.
Accurate detection of the tumor clone in peripheral T-cell lymphoma biopsies by flow cytometric analysis of TCR-Vß repertoire.
Mod Pathol
; 25(9): 1246-57, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22627740
14.
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.
Haematologica
; 95(8): 1350-7, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20220059
15.
Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.
Lancet Haematol
; 4(1): e46-e55, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28041583
16.
Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
J Clin Oncol
; 35(22): 2473-2481, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426350
17.
Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience.
J Clin Oncol
; 31(22): 2806-9, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23796999
18.
Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.
J Hematol Oncol
; 5: 27, 2012 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22682004
19.
Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte.
J Clin Oncol
; 28(5): 822-9, 2010 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20026809